Abstract
Advances in molecular biology and chemistry, like genetic engineering (recombinant DNA technique), sequence analysis of DNA and the automated chemical synthesis of oligopeptides, have made it possible to develop alternative vaccines (Table 1). Combined with immunological methods, these techniques allow the prior identification of protein(s) and determinants on proteins (epitopes) that are effective in triggering a protective immune response against the whole pathogen, as well as the large scale production of the protein or peptide identified as a potential vaccine. These developments are further supported by the search for suitable adjuvants, that will enhance the immunogenicity of nonreplicating vaccines without being toxic themselves.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acharya, R., Fry, E., Stuart, D., Fox, G., Rowlands, D. and Brown, F., 1989, The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution, Nature, 337:709.
Agterberg, M. and Tommassen, J., 1991, Outer membrane protein PhoE as a carrier for the exposure of foreign antigenic determinants at the bacterial cell surface, Antoine van Leeuwenhoek 59:249.
Aldovini, A. and Young, R.A., 1991, Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines, Nature (London), 351:479.
Benjamin, D.C., Berzofsky, J.A., East, I.J., Gurd, F.R., Hannum, C., Leach, S.J., Margoliash, E., Michael, J.G., Miller, A., Prager, E.M., Reichlin, M., Sercarz, E.E., Smith-Gill, S.J., Todd, P.E. and Wilson, A.C., 1984, The antigenic structure of proteins: a reappraisal, Annu.Rev,Immunol., 2:67.
Berzofsky, J.A., Bensussan, A., Cease, K.B., Bourge, J.F., Cheynier, R., Lurhuma, Z., Salaun, J.J., Gallo, R.C., Shearer, G.M. and Zagury, D., 1988, Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans, Nature, (London), 334:706.
Bittle, J.L., Houghten, R.A., Alexander, J., Shinnick, T.M., Sutcliffe, J.G., Lerner, R.A., Rowlands, D.J. and Brown, F., 1982, Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence, Nature (London), 298:30.
Bixler, G.S., Yoshida, T. and Atassi, M.Z., 1985, Antigen presentation of lysozyme: T-cell recognition of peptide and intact protein after priming with synthetic overlapping peptides comprising the entire protein chain, Immunology, 56:103.
Boere, W.A.M., Benaissa-Trouw, B.J., Harmsen, M., Kraaijeveld, C.A. and Snippe, H., 1983, Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest Virus can protect mice from lethal encephalitis, J. Gen.Virol., 64:1405.
Bontrop, R.E., Elferink, D.G., Otting, N., Jonker, M. and de Vries, R.R., 1990, Major histocompatibility complex class II-restricted antigen presentation across a species barrier: conservation of restriction determinants in evolution, J.Exp.Med., 172:53.
Borras-Cuesta, F., Petit-Camurdan, A. and Fedon, Y., 1987, Engineering of immunogenic peptides by co-linear synthesis of determinants recognized by B and T cells, Eur.J.Immunol., 17:1213.
Bostock, C.J., 1990, Viruses as vectors, Vet.Microbiol., 23:55.
Cannon, M.J., Openshaw, P.J. and Askonas, B.A., 1988, Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus, J.Exp,Med., 168:1.
Celis, E., Karr, R.W., Dietzschold, B., Wunner, W.H. and Koprowski, H., 1988, Genetic restriction and fine specificity of human T cell clones reactive with rabies virus, J,Immunol., 141:2721.
Celis, E., Ou, D., Dietzschold, B., Otvos, L.J. and Koprowski, H., 1989, Rabies virus-specific T cell hybridomas: identification of class II MHC-restricted T-cell epitopes using synthetic peptides, Hybridoma., 8:263.
Dalgarno, L., Rice, C.M. and Strauss, J.H., 1983, Ross River virus 26 s RNA: complete nucleotide sequence and deduced sequence of the encoded structural proteins, Virology, 129:170.
de Geus, P., van den Bergh, C.J., Kuipers, O., Verheij, H.M., Hoekstra, W.P. and de Haas, G.H., 1987, Expression of porcine pancreatic phospholipase A2. Generation of active enzyme by sequence-specific cleavage of a hybrid protein from Escherichia coli, Nucleic Acids Res., 15:3743.
Dietzschold, B., Gore, M., Marchadier, D., Niu, H.S., Bunschoten, H.M., Otvos, L.J., Wunner, W.H., Ertl, H.C., Osterhaus, A.D. and Koprowski, H., 1990, Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine, J.Virol., 64:3804.
Dimarchi, R., Brooke, G., Gale, C., Cracknell, V., Doel, T. and Mowat, N., 1986, Protection of cattle against foot-and-mouth disease by a synthetic peptide, Science, 232:639.
Doel, T.R., Gale, C., Do Amaral, C.M., Mulcahy, G. and Dimarchi, R., 1990, Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus, J.Virol., 64:260.
Ertl, H.C., Dietzschold, B., Gore, M., Otvos, L.J., Larson, J.K., Wunner, W.H. and Koprowski, H., 1989, Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein, J.Virol., 63:2885.
Francis, M.J., Hastings, G.Z., Syred, A.D., McGinn, B., Brown, F. and Rowlands, D.J., 1987, Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants, Nature (London), 300:168.
Gammon, G., Shastri, N., Cogswell, J., Wilbur, S., Sadegh Nasseri, S., Krzych, U., Miller, A. and Sercarz, E., 1987, The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site, Immunol.Rev., 98:53.
Garoff, H., Frischauf, A.M., Simons, K., Lerach, H. and Delius, H., 1980, Nucleotide sequence of cDNA coding for Semliki Forest Virus membrane proteins, Nature (London), 288:236.
Geysen, H.M., Meloen, R.H. and Barteling, S.J., 1984, Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid, Proc.Natl.Acad.Sci., USA, 81:3998.
Goudsmit, J., Debouck, C., Meloen, R.H., Smit, L., Bakker, M., Asher, D.M., Wolff, A.V., Gibbs, C.J.J. and Gajdusek, D.C., 1988, Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees, Proc.Natl,Acad,Sci., USA, 85:4478.
Halstead, S.B., 1988, Pathogenisis of dengue: challenges to molecular biology, Science, 239:476.
Ho, D.D., Sarngadharan, M.G., Hirsch, M.S., Schooley, R.T., Rota, T.R., Kennedy, R.C., Chanh, T.C and Sato, V.L., 1987, Human immunodeficiency virys neutralizing antibodies recognize several conserved domains on the envelope glycoproteins, J.Virol., 61:2024.
Hosmalin, A., Nara, P.L., Zweig, M., Lerche, N.W., Cease, K.B., Gard, E.A., Markham, P.D., Putney, S.D., Daniel, M.D., Desrosiers, R.C. and Berzofsky, J.A., 1991, Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates, J.Immunol., 146:1667.
Hunt, A.R., Johnson, A.J. and Roehrig, J.T., 1990, Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide, Virology, 179:701.
Ijaz, M.K., Attah Poku, S.K., Redmond, M.J., Parker, M.D., Sabara, M.I. and Babiuk, L.A., 1991, Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus, J.Virol., 65:3106.
Itoh, Y., Takai, E., Ohnuma, H., Kitajima, K., Tsuda, F., Machidam A., Mishiro, S., Nakamura, T., Miyakawa, Y. and Mayumi, M., 1986, A synthetic petpide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees, Proc.Natl,Acad.Sci. USA, 83:9174.
Javaherian, K., Langlois, A.J., McDanal, C., Ross, K.L., Eckler, L.I., Jellis, C.L., Profy, A.T., Rusche, J.R., Bolognesi, D.P., Putney, S.D. and Matthews, T.J., 1989, Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein, Proc.Natl.Acad,Sci., USA, 86:6768.
Klein, J., 1989, The MHC trans-species hypothesis: in the discussion period, Immunol.Suppl., 2:36.
Koolen, M.J., Borst, M.A., Horzinek, M.C. and Spaan, W.J., 1990, Immunogenic peptide comprising a mouse hepatitis virus A59 B-cell epitope and an influenza virus T-cell epitope protects against lethal infection, J.Virol., 64:6270.
Kurata, A., Palker, T.J., Streilein, R.D., Scearce, R.M., Haynes, B.F. and Berzofsky, J.A., 1989, Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells, J,Immunol., 143:2024.
Kusters, J.G., Jager, E.J., Lenstra, J.A., Koch, G., Posthumus, W.P., Meloen, R.H. and van der Zeijst, B.A., 1989, Analysis of an immunodominant region of infectious bronchitis virus, J,Immunol., 143:2692.
Laver, W.G., Air, G.M., Webster, R.G. and Smith Gill, S.J., 1990, Epitopes on protein antigens: misconceptions and realities, Cell, 61:553.
Lawrance, S.K., Karlsson, L., Price, J., Quaranta, V., Ron, Y., Sprent, J. and Peterson, P.A., 1989, Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha O mutant mice, Cell, 58:583
Milich, D.R., McLachlan, A., Thornton, G.B. and Hughes, J.L., 1987, Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site, Nature (London), 329:547.
Milich, D.R., 1989, Synthetic T and B cell recognition sites: implications for vaccine development, Adv.Immunol., 45:195.
Oehen, S., Hengartner, H. and Zinkernagel, R.M., 1991, Vaccination for disease, Science, 251:195.
Palker, T.J., Clark, M.E., Langlois, A.J., Matthews, T.J., Weinhold, K.J., Randall, R.R., Bolognesi, D.P. and Haynes, B.F., 1988, Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides, Proc,Natl.Acad.Sci. USA, 85:1932.
Panina-Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G. and Lanzavecchia, A., 1989, Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells, Eur.J.Immunol., 19:2237.
Partidos, C.D. and Steward, M.W., 1990, Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans, J.Gen.Virol., 71:2099.
Porterfield, J.S., 1986, Antibody-dependent enhancement of viral infectivity, Adv,Virus Res., 31:335.
Rusche, J.R., Javeherian, K., McDanal, C., Petro, J., Lynn, D.L., Grimalia, R., Langlois, A., Gallo, R.C., Arthur, L.O., Fischinger, P.J., Bolognesi, D.P., Putney, S.D. and Matthews, T.J., 1988, Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120, Proc.Natl.Acad.Sci., USA, 85:3198.
Sinigaglia, F., Guttinger, M., Kilgus, J., Doran, D.M., Matile, H., Etlinger, H., Trzeciak, A., Gillessen, D. and Pink, J.R., 1988, A malaria T-cell epitope recongized in association with most mouse and human MHC class II molecules, Nature (London), 336:778.
Snijders, A., Benaissa-Trouw, B.J., Oosting, J.D., Snippe, H. and Kraaijeveld, C.A., 1989, Identification of a DTH-inducing T-cell epitope on the E2 membrane protein of Semliki Forest Virus, Cell.Immunol., 123:23.
Snijders, A., Benaissa-Trouw, B.J., Oosterlaken, T.A.M., Puijk, W.C., Posthumus, W.P., Meloen, R.H., Boerce, W.A.M., Oosting, J.D., Kraaijeveld, C.A. and Snippe, H., 1991, Identification of linear epitopes on Semliki Forest Virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine, J.Gen,Virol., 72:557.
Snijders, A., Benaissa-Trouw, B.J., Visser-Vernooy, H.J., Fernandez, I., Snippe, H. and Kraaijeveld, C.A. (1992): A DTH-inducing T-cell epitope of Semliki Forest Virus mediates effective T helper activity for antibody production. Immunology, 72:99.
Steward, M.W., Stanley, C.M., Dimarchi, R., Mulcahy, G. and Doel, T.R., 1991, High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease, Immunology, 72:99.
Steward, M.W. and Howard, C.R., 1987, Synthetic peptides: a next generation of vaccines? Immunol.Today, 8:51.
Thole, J.E., van Schooten, W.C., Keulen, W.J., Hermans, P.W., Janson, A.A., de Vries, R.R., Kold, A.H. and van Embden, J.D., 1988, Use of recombinant antigens expressed in Escherichia coli K-12 to map B-cell and T-cell epitopes on the immunodominant 65-kilodalton protein of Mycobacterium bovis BCG, Infect.Immun., 56:1633.
Thornton, G.B., Milich, D.R., Chisary, F., Mitamura, K., Kent, S.B., Neurath, R., Purcell, R. and Gerin, J., 1987, Immune responses in primates to the pre-S2 region of hepatitis B surface antigen: identification of a protective determinant, in: “Vaccines, ‘87”, R.M. Chanock, R.A. Lerner, F. Brown and H. Ginsberg, eds. Cold Spring Harbor Laboratory, New York. 77.
Tokunaga, K., Saueracker, G., Kay, P.H., Christiansen, F.T., Anand, R. and Dawkins, R.L., 1988, Extensive deletions and insertions in different MHC supratypes detected by pulsed field gel electrophoresis, J.Exp.Med., 168:933.
Valenzuela, P., Medina, A., Rutter, W.J., Ammeter, G. and Hall, B.D., 1982, Synthesis and assembly of hepatitis B virus surface antigen particles in yeast, Nature (London), 298:347.
Van Regenmortel, M.H. and Daney de Marcillac, G., 1988, An assessment of prediction methods for locating continuous epitopes in proteins, Immunol.Lett., 17:95.
Vennema, H., de Groot, R.J., Harbour, D.A., Dalderup, M., Gruffydd Jones, T., Horzinek, M.C. and Spaan, W.J., 1990, Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization, J.Virol., 64:1407.
Vidal, S., Mottet, G., Kolakoky, D. and Roux, L., 1989, Addition of high-mannose sugars must precede disulfide bond formation for proper folding of Sendai virus glycoproteins, J.Virol., 63:892.
Vrati, S., Fernon, C.A., Dalgarno, L. and Weir, R.C., 1988, Location of a major antigenic site involved in Ross River virus neutralization, Virology, 162:346.
Wahlberg, J.M., Boere, W.A. and Garoff, H., 1989, The heterodimeric association between the membrane proteins of Semliki Forest Virus changes its sensitivity to low pH during virus maturation, J.Virol., 63:4991.
Wright, K.E., Salvato, M.S. and Buchmeier, M.J., 1989, Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expression, Virology, 171:417.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Snijders, A., Fernandez, I.M., Kraaijeveld, C.A., Snippe, H. (1993). Optimization of Carriers and Adjuvants a Model Study Using Semliki Forest Virus Infection of Mice. In: Gregoriadis, G., McCormack, B., Allison, A.C., Poste, G. (eds) New Generation Vaccines. NATO ASI Series, vol 261. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2948-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2948-4_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6281-4
Online ISBN: 978-1-4615-2948-4
eBook Packages: Springer Book Archive